Correlation Between Covalon Technologies and BetterLife Pharma

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Covalon Technologies and BetterLife Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Covalon Technologies and BetterLife Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Covalon Technologies and BetterLife Pharma, you can compare the effects of market volatilities on Covalon Technologies and BetterLife Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Covalon Technologies with a short position of BetterLife Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Covalon Technologies and BetterLife Pharma.

Diversification Opportunities for Covalon Technologies and BetterLife Pharma

-0.01
  Correlation Coefficient

Good diversification

The 3 months correlation between Covalon and BetterLife is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Covalon Technologies and BetterLife Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on BetterLife Pharma and Covalon Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Covalon Technologies are associated (or correlated) with BetterLife Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of BetterLife Pharma has no effect on the direction of Covalon Technologies i.e., Covalon Technologies and BetterLife Pharma go up and down completely randomly.

Pair Corralation between Covalon Technologies and BetterLife Pharma

Assuming the 90 days horizon Covalon Technologies is expected to under-perform the BetterLife Pharma. But the otc stock apears to be less risky and, when comparing its historical volatility, Covalon Technologies is 3.07 times less risky than BetterLife Pharma. The otc stock trades about -0.05 of its potential returns per unit of risk. The BetterLife Pharma is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  7.60  in BetterLife Pharma on October 25, 2024 and sell it today you would earn a total of  0.80  from holding BetterLife Pharma or generate 10.53% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Covalon Technologies  vs.  BetterLife Pharma

 Performance 
       Timeline  
Covalon Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Covalon Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable essential indicators, Covalon Technologies is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
BetterLife Pharma 

Risk-Adjusted Performance

3 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in BetterLife Pharma are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, BetterLife Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Covalon Technologies and BetterLife Pharma Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Covalon Technologies and BetterLife Pharma

The main advantage of trading using opposite Covalon Technologies and BetterLife Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Covalon Technologies position performs unexpectedly, BetterLife Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BetterLife Pharma will offset losses from the drop in BetterLife Pharma's long position.
The idea behind Covalon Technologies and BetterLife Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Other Complementary Tools

Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account